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Abstract:  The  regulation  of  the  inflammatory  response  is  essential  to  maintaining 
homeostasis. Several studies have investigated new drugs that may contribute to avoiding 
or minimizing excessive inflammatory process. The aim of this study was to evaluate the 
effect of extracts of green algae Caulerpa mexicana on models inflammation. In mice, the 
inflammatory peritonitis model is induced by zymosan. Previous treatment of mice with 
aqueous and methanolic extracts of C. mexicana was able to suppress the cell migration to 
the  peritoneal  cavity,  in  a  time-dependent  but  not  in  a  dose-dependent  manner.  The 
treatment of mice with C. mexicana extracts also decreased the xylene-induced ear edema, 
exerting strong inhibitory leukocyte migration elicited by zymosan into the air pouch. We 
concluded that administration of the extracts resulted in a reduction of cell migration to 
different sites as well as a decrease in edema formation induced by chemical irritants. This 
study  demonstrates  for  the  first  time  the  anti-inflammatory  effect  of  aqueous  and 
methanolic extracts from the green marine algae Caulerpa mexicana. 
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1. Introduction 
The plant kingdom is responsible for the largest share of chemical diversity recorded to date in the 
literature and has contributed significantly to the research and discovery of new drugs of natural origin, 
as well as the supply of useful substances for treating diseases that affect living beings [1–12]. Natural 
products of marine origin have recently been the object of intense interest in research because of their 
potential  pharmacological  activities  [13].  Marine  algae  are  responsible  for  creating  these  natural 
products,  producing  a  number  of  different  compounds  [14–16]  with  a  range  of  pharmacological 
activities [17–23]. 
Caulerpa  mexicana  is  a  member  of  marine  green  alga  Order  Bryopsidales  and  the  family 
Cauleparceae, which can be found in the temperate seas, but especially in tropical areas, such as the 
Brazilian Coastland [24]. These macrophytes are a source of several bioactive compounds, such as 
polysaccharides,  terpenes  and  indole  alkaloides,  which  exhibit  different  pharmacological  activities 
such as antitumor, antiviral, antioxidant and anticoagulant effects [25–27]. They also display antibiotic, 
cytotoxic and antimitotic activity [28] and some studies have reported that marine algae products have 
anti-inflammatory properties [27,29]. 
The inflammatory response consists of a wide variety of physiological and pathological processes. 
A key feature of the inflammatory response is leukocytes sequestration from the blood to the tissues, 
which occurs in a sequential process. Initially, locally produced inflammation mediators, such as, TNF, 
IL-1, and IL-6, activate the vascular endothelium, which starts to express adhesion molecules that 
mediate  tethering,  rolling  and  cell  adhesion.  Polymorphonuclear  cells  and  macrophages  reach  the 
tissues, migrate towards the inflammatory stimuli due to the chemokine gradient for phagocytes and 
eliminate the target [30]. An excessive inflammatory response can cause tissue damage. A well-regulated 
inflammatory  process  can protect the host against infections and remodel tissue structure, thereby  
re-establishing tissue function after injury. Acute inflammatory response, such as sepsis, can result in 
patient  death,  while  chronic  inflammations,  such  as  asthma  or  autoimmune  diseases,  can  cause 
irreversible tissue damage or induce organ failure [31,32]. Interestingly, there are no marine-derived 
anti-inflammatory natural products in clinical development at this time [33]. 
The regulation of inflammatory response is essential to maintain homeostasis, and several studies 
have  investigated  new  drugs  that  may  help  avoid  or  minimize  tissue  injury  caused  by  excessive 
inflammatory processes. The aim of this study was to evaluate the effect of extracts from the green 
alga Caulerpa mexicana in pro-inflammatory cytokines production by peritoneal macrophages in vitro, 
peritonitis, ear edema and air pouch inflammation in vivo. This is the first study to investigate the  
anti-inflammatory effect of the Caulerpa mexicana extracts in these inflammation models.  Mar. Drugs 2011, 9  
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2. Results 
2.1. The Effect of Caulerpa mexicana Extracts in vitro Production of Pro-Inflammatory Cytokines by 
Peritoneal Macrophages 
First, we evaluated the in vitro anti-inflammatory effect of C. mexicana extracts, by determining 
whether these extracts could stimulate in vitro production of pro-inflammatory cytokines by peritoneal 
macrophages. Macrophages were cultured with different doses (10, 5, and 0.5 µg/mL) of the extracts for 
24  h,  both  with  and  without  the  presence  of  lipopolysaccharide  (LPS)  from  the  cell  wall  of  
Gram-negative bacteria, which is known to stimulate the pro-inflammatory cytokines by these cells. As 
with cell cultured with  only culture medium (M), methanolic (ME)  and aqueous (AE) extracts of 
C. mexicana  alone  did  not  stimulate  IL-6  (Figure  1A),  IL-12  (Figure  1B)  or  TNF-α   (Figure  1C) 
production by peritoneal macrophages. As was expected, LPS was able to stimulate intense production 
of these cytokines. Interestingly, when peritoneal macrophages were cultured with the extracts in the 
presence of LPS there was decreased production of IL-6, IL-12 and TNF. The data suggest that the 
extracts used in this study are unable to activate macrophages to produce pro-inflammatory cytokines 
and  exhibit  anti-inflammatory  activity  by  inhibiting  the  production  of  the  cytokines  tested  in  the 
presence of LPS. 
Figure 1. Effect of methanolic (ME) and aqueous (AE) extracts of C. mexicana on the 
production of IL-6 (A), IL-12 (B) and TNF-α (C). Peritoneal macrophages were cultured 
with 10, 5 and 0.5 µg/mL of C. mexicana extracts for 24 h with and without the presence of 
LPS (100 ng/mL). * P ≤ 0.005, compared to medium (M) and extract-treated groups. 
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2.2. The Effect of Different Doses of Caulerpa mexicana Extracts on Zymosan-Induced Peritonitis  
in Mice 
Next, the in vivo anti-inflammatory effect of aqueous and methanolic extracts of C. mexicana was 
evaluated in a zymosan-induced peritonitis model. As expected, the animals treated intravenously (i.v.) 
with saline and 30 min later intraperitoneally (i.p.) with zymosan showed intense leukocyte migration 
to  the  peritoneal  cavity.  On  the  other  hand,  groups  treated  with  three  different  doses  (2,  0.4  or 
0.2 mg/kg) of methanolic (Figure 2A) or aqueous extracts (Figure 2B) showed a significant inhibition 
of  cell  migration  to  the  peritoneal  cavity  when  compared  with  the  group  administered  saline  i.v.  
and  zymosan  i.p.  A  reference  drug,  dexamethasone  (DEXA),  a  commercially  available  steroidal  
anti-inflammatory drug, was used for greater data reliability. As expected, DEXA treatment significantly 
inhibited cell migration to the peritoneum of animals administered with zymosan. Therefore, when 
compared with the positive control (ZYM  group), the drugs-treated  groups (DEXA, ME and  AE) 
exhibited anti-inflammatory activity, demonstrating impairment of leukocyte migration. However the 
effect of extracts was not dose-dependent, since the three doses tested induced similar inhibition of cell 
migration to the peritoneal cavity. 
Figure  2.  Effect  of  methanolic  and  aqueous  extracts  of  C.  mexicana  zymosa-induced 
peritonitis  model.  Swiss  mice  were  treated  intravenously  (i.v.)  with  methanolic  (A)  or 
aqueous  (B)  extract  at  doses  of  2,  0.4,  and  0.2  mg/kg  or  intraperitoneally  (i.p.)  with 
dexamethasone (0.5 mg/kg) and 30 min later were injected i.p. with 1 mL of zymosan 
(1 mg/mL).  After  six  hours,  peritoneal  lavage  was  performed  with  saline  and  the  cell 
number  determined  in  a  Neubauer  chamber.  *  P  ≤  0.0001,  compared  to  saline  and  
drug-treated groups. 
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2.3. The Effect of Caulerpa mexicana Extracts on the Kinetics of Zymosan-Induced Peritonitis in Mice 
After evaluating the effect of three different doses of C. mexicana extracts on zymosan-induced 
peritonitis,  we  then  evaluated  the  effects  of  these  extracts  in  the  kinetics  (6,  24  and  48  h)  of  
zymosan-induced peritoneal cell migration using one single dose of the extracts. The results presented 
in Figure 3 show that without extract or DEXA treatment, zymosan induced a marked increase in the Mar. Drugs 2011, 9  
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peritoneal cell migration in the three times analyzed (6, 24 and 48 h). However the previous treatment 
with  the  methanolic  and  aqueous  extracts  of  C.  mexicana  (2  mg/kg)  significantly  inhibited  the 
leukocyte  migration  to  the  peritoneal  cavity  during  the  time  points  studied,  similar  to  that  for 
dexamethasone. Extracts used in this study were therefore able to inhibit leukocyte migration to the 
peritoneal cavity even 48 h after zymosan inoculation. 
Figure  3.  Kinetics  of  effect  of  aqueous  and  methanolic  extracts  of  C.  mexicana  on 
zymosan-induced peritonitis. Swiss mice were treated intravenously with methanolic (ME) 
and aqueous (AE) (2 mg/kg) or intraperitoneally with dexamethasone (DEXA) at a dose of 
0.5 mg/kg. Thirty minutes later they were injected intraperitoneally with 1 mL of zymosan 
(1 mg/mL). Peritoneal wash with saline was performed at 6, 24 and 48 h and the cell 
number  determined  in  Neubauer  chamber.  ***  P  ≤  0.0001,  compared  to  saline  and  
drug-treated groups. 
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2.4. The Effect of Extracts of Caulerpa mexicana on Xylene-Induced Ear Edema 
After evaluating the effect of extracts of C. mexicana on the cell migration, we analyzed the effect 
of these extracts on another signal of inflammation: edema formation. The activity of methanolic and 
aqueous  extracts  of  C.  mexicana  against  xylene-induced  ear  edema  is  presented  in  the  Table  1. 
Treating  mice  with  2  and  0.4  mg/kg  doses  of  methanolic  extract  suppressed  xylene-induced  ear  
edema, reducing swelling by 73.55% and 77.07% after 15 min and by 83.75% and 85.63% after 1 h, 
respectively compared to the vehicle-treated group. On the other hand, when aqueous extract activity 
was analyzed, it was observed that the dose of 0.4 mg/kg reduced ear edema by 84.83% after 15 min 
and by 93.18% after 1 h, while the 2 mg/kg dose showed 25% and 36.88% ear edema inhibition  
15  min  and  1  h  after  analysis,  respectively.  Dexamethasone  administration  showed  a  decrease  of 
70.60% after 15 min and 73.37% 1 h after ear edema induction. 
2.5. Effect of Caulerpa mexicana Extracts on the Zymosan-Injected Mouse Air Pouch 
Zymosan injected into a mouse air pouch induced an acute inflammatory response characterized by 
plasma exudation and leukocyte infiltration to the cavity. This demonstrated that previous treatment of 
mice  with  the  two  different  doses  of  the  aqueous  extract  of  C.  mexicana  or  with  dexamethasone 
significantly decreased the pro-inflammatory effect of zymosan, thus reducing the cell migration to the Mar. Drugs 2011, 9  
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inflammation  site.  However,  methanolic  extract  was  able  to  decrease  the  zymosan-induced  cell 
migration into the air pouch only at a dose of 2 mg/kg (Figure 4). 
Table 1. Anti-inflammatory effects of extracts on xylene-induced ear edema in mice. 
Groups 
15 min  1 h 
Dose 
(mg/kg) 
Difference 
(mg) 
Inhibition 
(%) 
Difference 
(mg) 
Inhibition 
(%) 
Saline (i.v.)  –  32.45 ± 2.603  –  31.80 ± 5.289  – 
Methanolic 
Extract (s.c.) 
0.4 
2 
7.475 ± 2.809 
8.453 ± 3.500 
77.07% ** 
73.55% ** 
4.567 ± 2.668 
5.167 ± 2.580 
85.63% ** 
83.75% ** 
Aqueous 
Extract (s.c.) 
0.4 
2 
4.933 ± 4.916 
24.45 ± 5.212 
84.86% *** 
25% 
2.167 ± 3.316 
20.07 ± 5.029 
93.18% ** 
36.88% 
Dexa (i.p.)  0.5  9.600 ± 2.419  70.60% **  8.467 ± 2.850  73.37% ** 
Values are mean ± standard deviation (S.D.), n = 5, ** p < 0.001, *** p < 0.0001, compared to 
saline group. 
Figure 4. Effect of aqueous and methanolic extracts of C. mexicana on the leukocytes 
migration into the air pouch model. The animals were treated with saline or two different 
doses of aqueous (AE) or methanolic (ME) extract or with 0.5 mg/kg of dexamethazone 
(DEXA) and 30 min later receive 1 mL of zymosan solution (1 mg/mL) in the air pouch. 
Leukocyte  migration  was  evaluated  24  h  after  zymosan  injection  into  the  air  pouch.  
(A) * P ≤ 0.001, compared to saline and drug-treated groups; (B) * P ≤ 0.05, compared to 
saline, ME (2 mg/kg) and DEXA groups. 
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After  analyzing  the  dose  response  of  aqueous  and  methanolic  extracts  of  C.  mexicana  on  
zymosan-induced leukocyte accumulation into the mouse air pouch, we evaluated the kinetics of this 
response (6, 24 and 48 h) using a fixed dose of these extracts (2 mg/kg). Figure 5 shows that the 
aqueous and methanolic extract of C. mexicana significantly decreased cell migration to the dorsal 
cavity at 24 and 48 h after zymosan injection. Inhibition of cell migration by the extracts was similar to 
that one induced by dexamethasone, which inhibited cell migration to the air pouch cavity at the three 
time points analyzed.  Mar. Drugs 2011, 9  
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Figure 5. Effect of methanolic and aqueous extracts of C. mexicana on the kinetic of cell 
migration into the air pouch. The animals were treated with saline (SAL), 2 mg/mL of the 
aqueous (AE) or methanolic (ME) extract or with 0.5 mg/kg of dexamethazone (DEXA) 
and 30 min later received 1 mL of zymosan solution (1 mg/mL) in their air pouch. At the 
time points indicated, leukocyte number was determined after zymosan injection into the 
air pouch. * P ≤ 0.05, compared to saline and drug-treated groups. 
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3. Discussion 
In this study we have examined the anti-inflammatory effect of aqueous and methanolic extracts of 
Caulerpa  mexicana,  analyzing  their  effects  on  in  vitro  pro-inflammatory  and  immune  stimulatory 
cytokine production by peritoneal macrophages, as well as on different in vivo inflammation models, 
such as peritonitis and zymosan-induced air pouch cell migration and xylene-induced ear edema.  
Macrophages activation is an important cell in immune and inflammatory response, which can start 
after microbial products interact with pattern recognition receptors (PRR) present in the macrophages’ 
membranes. LPS from the cell wall of Gram negative bacteria is a classical example of a microbial 
product that can activate macrophages through PRR and induce pro-inflammatory cytokine production, 
such as IL-6, IL-1 and TNF, as well as immunostimulatory cytokine, as IL-12 [34]. To determine if the 
extracts of C. mexicana could have any stimulatory activity in macrophages, we cultured these cells 
with different doses of the methanolic and aqueous extracts for 24 h, with and without the presence of 
LPS. The results are interesting because extracts alone did not stimulate pro-inflammatory cytokine 
production and were able to inhibit production of these LPS-induced cytokines, exhibiting in vitro  
anti-inflammatory activity. Moreover, mechanisms of action of these extracts remain unknown, one 
possibility being that they contain substances that inhibit or compete [35] with the LPS ligand, the 
Toll-like receptor 4 (TLR4) or CD14 molecule, which is a co-receptor for LPS [36], or bind with some 
molecules on the macrophage surface, inhibiting LPS-induced biochemical signals for pro-inflammatory 
cytokine  production  [37].  Further  investigations  will  focus  on  the  chemical  identification  and 
mechanisms of action of the major active components responsible for anti-inflammatory activity in 
C. mexicana extracts. 
As we did not observe in vitro macrophage activation induced by the extracts of C. mexicana, the 
next step was to determine if they could have any anti-inflammatory activity in in vivo inflammatory 
models. Peritonitis is a serious infection that often leads to multiple organ failure, septicemia, and Mar. Drugs 2011, 9  
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mortality [38]. Acute inflammatory reactions can be induced experimentally by a variety of substances. 
Zymosan,  the  insoluble  polysaccharide  component  of  the  Saccharomyces  cerevisiae  cell  wall  is 
commonly used to induce acute peritonitis in mice [39]. This study showed that the aqueous and 
methanolic extracts exerted an anti-inflammatory effect, reducing zymosan-induced cell recruitment 
into  the  peritoneal  cavity.  These  data  are  consistent  with  the  results  of  the  studies  demonstrating  
that  extracts  of  alga  C.  racemosa  as  well  as  purified  alkaloids  from  the  genus  Caulerpa  showed  
anti-inflammatory and analgesic activity [40,41]. The process by which the extracts used in this study 
inhibit cell migration in response to inflammatory stimuli has yet to be elucidated. One possibility is 
that these extracts contain substances that act in an inhibitory or competitive fashion with zymosan, 
interacting with one of the zymosan’s receptors in the cell surfaces, the Toll like receptor 2 (TLR2) [42], 
blocking  cell  adhesion  to  vascular  endothelium  [43]  or  inhibiting  the  macrophages’  activation  via 
scavenger  receptors  [44].  We  did  not  detect  any  statistical  difference  in  pharmacological  action 
between  the  doses  of  aqueous  and  methanolic  extracts  tested  in  this  model.  We  believe  that  this 
occurred because dose concentration was very similar and may therefore be in the therapeutic window, 
because  when  a  previous  experiment  was  conducted  using  a  dose  of  20  mg/kg,  there  was  no  
anti-inflammatory activity (data not shown). Another important point to consider is that when some 
pharmacological preparations are made from one plant extract, different solvents are used as carrier, 
thereby  obtaining  the  highest  possible  number  of  components.  The  absence  of  a  difference  in  
anti-inflammatory activity when methanolic or aqueous extracts were used may be due to the solvents 
used  (water  and  methanol),  which,  in  addition  to  being  chemically  different,  may  have  extracted 
similar components that are responsible for the anti-inflammatory activity observed in our models. In 
some Caulerpa species, for example C. racemosa, purified indole alkaloids, such as caulerpin, have 
proven  anti-inflammatory  activity  [41].  Therefore,  new  studies  are  needed  to  isolate  the  extract 
compounds and evaluate their mechanisms of action. 
Xylene-induced ear edema was adopted as the acute inflammatory model, since it has frequently 
been used to evaluate the anti-inflammatory effects of natural products and has good predictive value 
in the screening anti-inflammatory agents [45,46]. Xylene-induced ear edema in this study led to fluid 
accumulation  and  edema,  characteristic  of  the  acute  inflammatory  response.  The  xylene-induced 
inflammation  caused  the  release  of  proinflammatory  mediators  from  sensory  neurons  that  act  on 
peripheral target cells, such as mast cells and other immune cells, producing neurogenic inflammation 
characterized by warmth, redness and edema [47]. Suppression of this response is a likely indication of 
antiphlogistic  effect  [46]  and  the  results  clearly  showed  that  methanolic  and  aqueous  extracts  of  
C. mexicana exerted significant antiphlogistic effects against xylene-induced ear edema. These data 
are  consistent  with  the  studies  showing  that  plant  extracts  from  traditional  Tibetan  and  Chinese 
medicine [45,46] and seaweed extracts [48] presented significant reduction in the ear edema in mice. 
The local zymosan-induced inflammatory response in the air pouch in mice is considered similar to 
the inflammatory response of synovial tissue [48] due to injection of sterile air into the backs of mice, 
forming a cell-lined cavity resembling the synovial membrane [49,50]. Therefore, when injected into 
the cavity, zymosan is  phagocytosed, inducing  degranulation  and neutrophil respiratory  burst,  and 
production of several inflammatory mediators such as myeloperoxidase, eicosanoids, phospholipase A2, 
nitric oxide, tumor necrosis factor-α (TNF-α) and interleukin 1 (IL-1) and IL-6 [50]. This model was 
used to investigate the anti-inflammatory effect of aqueous and methanolic extracts of C. mexicana, Mar. Drugs 2011, 9  
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measuring the number of leukocytes migration to the air pouch. The extracts tested in our experiments, 
proved to have anti-inflammatory agents, similarly to those observed in [51,52], leading us to speculate 
on  the  substance  contained  in  these  extracts  that  exert  an  anti-inflammatory  activity  and  their 
mechanism of action, issues of interest for future study. The mechanism used by the methanolic and 
aqueous extract in this inflammation model is still unknown, but we suggest that it may be due to 
endothelium receptor binding, thereby preventing leukocyte rolling into the dorsal cavity, as well as 
inhibiting the production of cytokines responsible for triggering the inflammatory process [42,44]. 
Interestingly, when we compared experimental ear edema and air pouch inflammation models, we 
observed that a 2 mg/kg dose of aqueous extract was much more effective in inhibiting cell migration 
to the air pouch model than reducing xylene-induced edema formation in the ear. We believe that this 
difference may have occurred because of the different experimental models used, possibly exhibiting 
different  mechanisms  of  action,  or  because  of  different  administration  routes.  Since  the  bioactive 
compound  responsible  for  biological  activity  has  yet  to  be  identified  and  the  manner  in  which  it 
operates in animal organisms is still unknown, it is suggested that future trials involve bioassay-guided 
fractionation of these extracts. 
4. Experimental 
4.1. Extraction and Isolation 
The alga C. mexicana was collected in the coastal region of Bessa (7°03′52″S/34°49′51″W), Joao 
Pessoa, Paraiba State, Brazil in April 2008. The specimen was identified by Dr. George Emmanuel 
Cavalcanti de Miranda. Voucher specimens of C. mexicana (JPB 13985) have been deposited in the 
Lauro  Pires  Xavier  Herbarium  at  the  Federal  University  of  Paraiba,  Brazil.  Fresh  algae  were 
lyophilized and exhaustively extracted with methanol and water in a Soxhlet apparatus, to obtain the 
respective extracts. 
4.2. Animal 
Male Swiss albino and BALB/c mice (6–8 weeks old) were used in the experiment. All mice were 
housed, 5–6 per cage at a room temperature of 22 ± 2 °C, and a 12 h:12 h light/dark cycle. They had 
free access to food and water. Groups of five animals were used in each test group and control animals 
received saline only. All in vivo experiments were approved by the local ethics committee. 
4.3. Peritoneal Macrophage Cell Culture 
BALB/c mice were inoculated with 1 mL of sterile 3% sodium thioglycollate (Sigma). After three 
days the animals were killed and macrophages harvested by washing their peritoneal cavity with 5 mL 
of cold 0.9% w/v sterile saline. The cell suspension was centrifuged at 250× g for 10 min at 4 °C, the 
supernatant discarded, the cell bottom dissolved in 1 mL  of incomplete medium and cell number 
determined using a Neubauer chamber. One ml of cell suspension (1 × 10
6/mL) was incubated for 2 h 
for the macrophage adhesion to the 24-well cell culture plate. Non-adherent cells were harvested by 
three repeat washing with 1 mL of cell culture medium. Adherent cells were incubated with different 
doses of methanolic and aqueous extracts of C. mexicana (50, 10 and 5 µg/mL) and one hour after the Mar. Drugs 2011, 9  
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cells were incubated with the extracts, LPS (100 ng/mL) was added to one group. Macrophages were 
also incubated only with medium or LPS as a negative and positive control, respectively. After 24 h of 
cell culture, supernatants were collected for determination of IL-6, IL-12 and TNF-α  levels, which 
was performed using an enzyme-linked immunosorbent assay kit from Ebioscience. 
4.4. Induction of Peritonitis 
Peritoneal inflammation was induced according to the procedure described previously in [39] with a 
few modifications. Animals were inoculated intravenously (i.v.) with saline, methanolic or aqueous 
extracts (2, 0.4, or 0.2 mg/kg) of C. mexicana or intraperitonealy with dexamethasone (0.5 mg/kg). 
Thirty  minutes  later,  the  animals  were  injected  intraperitoneally  with  0.9%  w/v  sterile  saline  or 
zymosan A (Sigma), freshly prepared (1 mL of 1% w/v) in sterile saline. At the selected time points  
(6, 24, and 48 h), the animals were killed by cervical dislocation, and peritoneal exudates harvested by 
peritoneal wash with 5 mL of cold saline. Exudates were centrifuged at 250× g for 10 min, at 4 °C, and 
the total cells number determinate in hemocytometer following staining with Turk’s solution. 
4.5. Xylene-Induced Ear Edema 
The effects of extracts on acute topical inflammation were evaluated  according [46]. The mice  
were treated intravenously with saline, methanolic or aqueous extracts of C. mexicana (2 mg/kg and  
0.4 mg/kg) or intraperitonealy with 0.5 mg/kg of dexamethasone. Thirty minutes after the treatment, 
ear edema was induced by applying 0.04 mL of xylene (Merk) to the anterior and posterior surfaces of 
the right ear. The left ear was considered as control and only saline was applied. Fifteen minutes and 
one hour after xylene application, mice were killed and both ears were removed. Circular sections were 
taken, using a cork borer with a diameter of 7 mm, and weighed. Inhibition level (%) was calculated 
according to the following equation: 
Inhibition (%) = [1 − Et/Ec] × 100  (1)  
where Et = average edema in the treated group, and Ec = average edema of the control group. 
4.6. Mouse Air Pouch Model 
The air pouch was produced in mice as previously described [49,53]. Briefly, 3 mL of sterile air 
was subcutaneously injected into the back of the experimental animals. Three days later 1.5 mL of 
sterile air was injected into the cavity. Six days after the initial air injection, animals were injected 
intravenously,  with  methanolic  or  aqueous  extract  (2  mg/kg,  0.4  mg/kg  and  0.2  mg/kg)  or 
intraperitoneally with dexamethasone (0.5 mg/kg). Thirty minutes later zymosan solution (1 mL of 
1% w/v) was injected into the air pouch. At the selected time points (6, 24, and 48 h), animals were 
killed by cervical dislocation and exudates harvested from each air pouch by washing them out with 
1 mL of 0.9% w/v sterile saline. The exudates collected from each mouse were centrifuged at 250× g 
for 10 min at 4 °C; the cell bottom was diluted in 1 mL of saline and the number of cells determined  
in hemacytometer. Mar. Drugs 2011, 9  
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5. Conclusions 
In  conclusion,  this  is  the  first  study  to  evaluate  the  anti-inflammatory  activity  of  extracts  of 
Caulerpa mexicana using microbial products. In vitro data demonstrate that the extracts were unable to 
stimulate macrophages to produce IL-6, IL-12 and TNF-α, but were able to inhibit the production of 
these LPS-induced cytokines, showing in vitro anti-inflammatory activity.  In in vivo studies using 
zymosan-induced  peritonitis,  air  pouch  inflammation  and  xylene-induced  ear  edema  exhibited  a 
significant  anti-inflammatory  effect.  Further  studies  are  required  to  determine  the  chemical 
composition of C. mexicana extracts and their possible anti-inflammatory mechanisms of action. 
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